LifeMD Cost of Revenue vs Price to Sales Ratio Analysis

LFMD Stock  USD 10.37  0.19  1.87%   
LifeMD financial indicator trend analysis is infinitely more than just investigating LifeMD Inc recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether LifeMD Inc is a good investment. Please check the relationship between LifeMD Cost Of Revenue and its Price To Sales Ratio accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in LifeMD Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.

Cost Of Revenue vs Price To Sales Ratio

Cost of Revenue vs Price to Sales Ratio Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of LifeMD Inc Cost of Revenue account and Price to Sales Ratio. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between LifeMD's Cost of Revenue and Price to Sales Ratio is -0.5. Overlapping area represents the amount of variation of Cost of Revenue that can explain the historical movement of Price to Sales Ratio in the same time period over historical financial statements of LifeMD Inc, assuming nothing else is changed. The correlation between historical values of LifeMD's Cost of Revenue and Price to Sales Ratio is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cost of Revenue of LifeMD Inc are associated (or correlated) with its Price to Sales Ratio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Price to Sales Ratio has no effect on the direction of Cost of Revenue i.e., LifeMD's Cost of Revenue and Price to Sales Ratio go up and down completely randomly.

Correlation Coefficient

-0.5
Relationship DirectionNegative 
Relationship StrengthVery Weak

Cost Of Revenue

Cost of Revenue is found on LifeMD Inc income statement and represents the costs associated with goods and services LifeMD provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Price To Sales Ratio

Price to Sales Ratio is figured by comparing LifeMD Inc stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on LifeMD sales, a figure that is much harder to manipulate than other LifeMD Inc multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company’s stock price to its revenues, calculated by dividing the company’s market cap by its total sales or revenue over a 12-month period.
Most indicators from LifeMD's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into LifeMD Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in LifeMD Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.
At present, LifeMD's Discontinued Operations is projected to increase significantly based on the last few years of reporting. The current year's Tax Provision is expected to grow to about 449.4 K, whereas Issuance Of Capital Stock is forecasted to decline to about 854.6 K.
 2021 2022 2023 2024 (projected)
Interest Expense3.0M1.3M2.6M2.7M
Depreciation And Amortization4.9M7.5M6.6M6.9M

LifeMD fundamental ratios Correlations

0.860.950.940.480.76-0.76-0.940.880.960.880.960.890.030.950.840.810.970.950.760.990.390.070.890.95-0.34
0.860.820.840.070.4-0.37-0.820.720.740.890.740.970.130.831.00.720.840.930.40.80.260.180.950.93-0.66
0.950.820.970.340.83-0.65-0.970.880.850.940.850.890.110.990.770.910.980.960.830.90.610.140.910.95-0.45
0.940.840.970.240.79-0.59-1.00.950.810.960.810.920.00.990.790.941.00.980.790.880.650.040.940.92-0.55
0.480.070.340.240.54-0.92-0.250.290.70.040.70.04-0.080.290.080.070.320.20.540.61-0.19-0.070.030.280.66
0.760.40.830.790.54-0.74-0.810.740.720.680.720.54-0.170.810.340.750.810.681.00.740.68-0.150.580.65-0.09
-0.76-0.37-0.65-0.59-0.92-0.740.6-0.63-0.9-0.39-0.9-0.380.1-0.62-0.37-0.41-0.65-0.54-0.74-0.85-0.080.08-0.38-0.58-0.34
-0.94-0.82-0.97-1.0-0.25-0.810.6-0.94-0.81-0.96-0.81-0.910.02-0.99-0.77-0.94-1.0-0.97-0.81-0.88-0.66-0.02-0.93-0.910.54
0.880.720.880.950.290.74-0.63-0.940.790.830.790.8-0.050.920.670.890.930.90.740.840.62-0.020.820.82-0.44
0.960.740.850.810.70.72-0.9-0.810.790.71.00.73-0.010.840.730.630.860.830.720.990.180.030.720.86-0.06
0.880.890.940.960.040.68-0.39-0.960.830.70.70.960.070.950.850.930.950.970.680.780.650.110.980.92-0.71
0.960.740.850.810.70.72-0.9-0.810.791.00.70.73-0.010.840.730.630.860.830.720.990.180.030.720.86-0.06
0.890.970.890.920.040.54-0.38-0.910.80.730.960.730.10.910.950.840.910.970.540.810.450.140.990.93-0.71
0.030.130.110.0-0.08-0.170.10.02-0.05-0.010.07-0.010.10.060.150.18-0.010.05-0.170.020.011.00.070.19-0.09
0.950.830.990.990.290.81-0.62-0.990.920.840.950.840.910.060.780.940.990.970.810.90.640.10.930.94-0.5
0.841.00.770.790.080.34-0.37-0.770.670.730.850.730.950.150.780.660.790.90.340.790.170.20.920.91-0.62
0.810.720.910.940.070.75-0.41-0.940.890.630.930.630.840.180.940.660.920.890.750.720.810.20.870.83-0.63
0.970.840.981.00.320.81-0.65-1.00.930.860.950.860.91-0.010.990.790.920.980.810.920.60.020.930.93-0.49
0.950.930.960.980.20.68-0.54-0.970.90.830.970.830.970.050.970.90.890.980.680.890.520.090.980.96-0.6
0.760.40.830.790.541.0-0.74-0.810.740.720.680.720.54-0.170.810.340.750.810.680.740.68-0.150.580.65-0.09
0.990.80.90.880.610.74-0.85-0.880.840.990.780.990.810.020.90.790.720.920.890.740.270.060.80.91-0.18
0.390.260.610.65-0.190.68-0.08-0.660.620.180.650.180.450.010.640.170.810.60.520.680.270.020.530.42-0.55
0.070.180.140.04-0.07-0.150.08-0.02-0.020.030.110.030.141.00.10.20.20.020.09-0.150.060.020.110.23-0.12
0.890.950.910.940.030.58-0.38-0.930.820.720.980.720.990.070.930.920.870.930.980.580.80.530.110.94-0.73
0.950.930.950.920.280.65-0.58-0.910.820.860.920.860.930.190.940.910.830.930.960.650.910.420.230.94-0.51
-0.34-0.66-0.45-0.550.66-0.09-0.340.54-0.44-0.06-0.71-0.06-0.71-0.09-0.5-0.62-0.63-0.49-0.6-0.09-0.18-0.55-0.12-0.73-0.51
Click cells to compare fundamentals

LifeMD Account Relationship Matchups

LifeMD fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets3.4M13.1M49.9M25.7M58.5M61.4M
Short Long Term Debt Total844.7K1.1M1.8M4.1M18.9M19.9M
Other Current Liab3.1M1.4M11.6M12.2M13.9M14.6M
Total Current Liabilities4.0M13.5M22.8M31.4M34.8M36.5M
Total Stockholder Equity(988.2K)1.4M26.9M(6.8M)3.5M2.1M
Net Debt(261.9K)(8.1M)(39.5M)168.5K(14.2M)(13.5M)
Retained Earnings(16.6M)(80.2M)(141.9M)(190.6M)(214.3M)(203.6M)
Accounts Payable3.1M10.4M9.1M10.1M11.1M11.6M
Cash1.1M9.2M41.3M4.0M33.1M34.8M
Non Current Assets Total699.1K990.3K5.0M14.4M15.9M16.7M
Cash And Short Term Investments1.1M9.2M41.3M4.0M33.1M34.8M
Net Receivables97.4K648.4K980.1K2.8M5.3M5.5M
Common Stock Total Equity534.0K234.3K307.0K315.5K362.9K377.1K
Common Stock Shares Outstanding10.6M14.3M27.0M31.0M33.9M35.6M
Liabilities And Stockholders Equity3.4M13.1M49.9M25.7M58.5M61.4M
Non Current Liabilities Total600.0K385.3K1.3M1.6M18.1M19.0M
Inventory950.1K1.3M1.6M3.7M2.8M2.9M
Other Stockholder Equity15.1M77.6M164.4M178.9M217.4M228.3M
Total Liab4.6M13.9M24.1M33.0M52.9M55.6M
Total Current Assets2.7M12.1M44.9M11.3M42.6M44.7M
Short Term Debt814.7K779.1K670.9K3.6M930.8K715.0K
Common Stock534.0K234.3K307.0K315.5K383.6K380.6K
Current Deferred Revenue109.6K916.9K1.5M5.5M8.8M9.3M
Other Current Assets443.0K154.9K793.2K687.0K1.4M1.5M
Net Tangible Assets(1.7M)(3.0M)19.7M(19.5M)(17.6M)(16.7M)
Net Invested Capital(173.5K)(1.5M)22.8M(8.6M)21.8M22.8M
Short Long Term Debt814.7K779.1K63.4K2.8M327.6K311.2K
Net Working Capital(1.2M)(1.4M)22.1M(20.1M)7.8M8.2M
Capital Stock534.0K3.9M4.4M4.9M383.7K364.5K
Intangible Assets675.5K715.8K3.0M12.7M14.8M15.5M

LifeMD Investors Sentiment

The influence of LifeMD's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in LifeMD. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to LifeMD's public news can be used to forecast risks associated with an investment in LifeMD. The trend in average sentiment can be used to explain how an investor holding LifeMD can time the market purely based on public headlines and social activities around LifeMD Inc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
LifeMD's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for LifeMD's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average LifeMD's news discussions. The higher the estimated score, the more favorable is the investor's outlook on LifeMD.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards LifeMD in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, LifeMD's short interest history, or implied volatility extrapolated from LifeMD options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether LifeMD Inc is a strong investment it is important to analyze LifeMD's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact LifeMD's future performance. For an informed investment choice regarding LifeMD Stock, refer to the following important reports:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in LifeMD Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.
You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Complementary Tools for LifeMD Stock analysis

When running LifeMD's price analysis, check to measure LifeMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LifeMD is operating at the current time. Most of LifeMD's value examination focuses on studying past and present price action to predict the probability of LifeMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LifeMD's price. Additionally, you may evaluate how the addition of LifeMD to your portfolios can decrease your overall portfolio volatility.
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Is LifeMD's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of LifeMD. If investors know LifeMD will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about LifeMD listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.70)
Revenue Per Share
4.499
Quarterly Revenue Growth
0.595
Return On Assets
(0.22)
Return On Equity
(7.82)
The market value of LifeMD Inc is measured differently than its book value, which is the value of LifeMD that is recorded on the company's balance sheet. Investors also form their own opinion of LifeMD's value that differs from its market value or its book value, called intrinsic value, which is LifeMD's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because LifeMD's market value can be influenced by many factors that don't directly affect LifeMD's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between LifeMD's value and its price as these two are different measures arrived at by different means. Investors typically determine if LifeMD is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, LifeMD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.